Agiomix Appoints Dr. Cengiz Yakicier as a Senior Member of its Medical Board
Dubai, UAE, (June, 2019) – Agiomix, the next generation genomics company has announced the appointment of a leading physician-scientist, Dr. Cengiz Yakicier to the position of Medical Director with immediate effect. As a member of Agiomix medical board Dr. Cengiz will be responsible for developing and executing on the company’s medical strategy to drive genomic analysis across healthcare practices in the region.
“We are very excited to welcome Dr. Cengiz to our team of medical experts. This is a transformative time in the evolution of precision and translational medicine and Dr. Cengiz will add a lot to our services to the healthcare community” said Dr. John Clarkson Board Director of Agiomix FZ-LLC.
For over three decades, Dr. Cengiz has worked at leading institutions throughout Asia, Europe and US; he currently serves as the Director of the Molecular Pathology Laboratory at Acıbadem in Istanbul. He is Founding Dean of Faculty of Science and Arts at Acıbadem University.
Dr. Cengiz holds an MD degree in Nuclear Medicine, he also holds Master’s and PhD degrees in Molecular Genetic from University Claude Bernard, Lyon, France, where he served as a research fellow; he also served as a research fellow at the Gastrointestinal Unit of Massachusetts General Hospital at Harvard Medical School in Boston, USA. Dr. Cengiz has numerous publications in renowned medical journals.
Dr. Cengiz said: “I am delighted to join the Agiomix Medical Board, I believe that Agiomix has the right lab infrastructure and medical expertise to provide truly outstanding and world-class genomics services, I am looking forward to adding value to Agiomix ability to analyze complex pathologies and produce excellent medical reports to aid in the diagnosis and management of disease.”
Check out the Press Release https://www.biochannelpartners.com/node/586